Assignee
CENTREXION THERAPEUTICS CORP
US·34 granted patents·16 pending applications·98 citations·filing 2014–2025
Top patents by PatentIndex Score
50 records- 0196US11344516B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2020·Granted May 31, 2022·3 cites·32 claims
- 0296US10493047B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Dec 3, 2019·8 cites·30 claims
- 0395US10772853B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Sep 15, 2020·5 cites·30 claims
- 0495US10765649B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Sep 8, 2020·5 cites·30 claims
- 0594US11147814B2(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p- tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrateCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Oct 19, 2021·5 cites·20 claims
- 0694US11026903B2Methods and compositions for treatment of pain using capsaicinCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Jun 8, 2021·3 cites·28 claims
- 0794US11000490B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted May 11, 2021·4 cites·13 claims
- 0893US10568885B2(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-y1)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-citrateCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Feb 25, 2020·6 cites·24 claims
- 0993US10213428B2(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrateCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Feb 26, 2019·7 cites·30 claims
- 1091US11725004B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 15, 2023·1 cites·16 claims
- 1191US11084810B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Aug 10, 2021·2 cites·18 claims
- 1291US11046706B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 29, 2021·3 cites·26 claims
- 1391US10196402B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Feb 5, 2019·7 cites·31 claims
- 1489US11731981B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 22, 2023·1 cites·20 claims
- 1589US10570125B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Feb 25, 2020·4 cites·20 claims
- 1689US9670222B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2014·Granted Jun 6, 2017·9 cites·23 claims
- 1789US2024423931A1Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1888US10112934B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Oct 30, 2018·4 cites·25 claims
- 1986US12344601B2(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 2086US12209094B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jan 28, 2025·0 cites·20 claims
- 2186US9789082B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2016·Granted Oct 17, 2017·5 cites·38 claims
- 2285US10758502B2High concentration local anesthetic formulationsCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Sep 1, 2020·1 cites·21 claims
- 2385US10675268B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 9, 2020·2 cites·15 claims
- 2485US10166214B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Jan 1, 2019·4 cites·25 claims
- 2584US9650370B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2014·Granted May 16, 2017·5 cites·32 claims
- 2684US2025312298A1Methods and compositions for treatment of pain using capsaicinCENTREXION THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 2782US11992470B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2022·Granted May 28, 2024·0 cites·20 claims
- 2882US11447444B1Capsaicinoid prodrug compounds and their use in treating medical conditionsCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Sep 20, 2022·1 cites·20 claims
- 2981US11254659B1Capsaicinoid prodrug compounds and their use in treating medical conditionsCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Feb 22, 2022·1 cites·20 claims
- 3078US11045459B1Compositions and methods for intrathecal administration of MCOPPB for pain reliefCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Jun 29, 2021·2 cites·23 claims
- 3176US12268679B1Compositions and methods for epidural administration of MCOPPB for pain reliefCENTREXION THERAPEUTICS CORP·Filed 2022·Granted Apr 8, 2025·0 cites·30 claims
- 3276US12076321B2(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrateCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Sep 3, 2024·0 cites·20 claims
- 3376US11820727B1Capsaicinoid prodrug compounds and their use in treating medical conditionsCENTREXION THERAPEUTICS CORP·Filed 2022·Granted Nov 21, 2023·0 cites·20 claims
- 3476US2025241879A1Capsaicin sequential dosing method for treatment of knee joint painCENTREXION THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 3575US2024285603A1Compositions and methods for intrathecal administration of mcoppb for pain reliefCENTREXION THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 3673US12201594B2Methods and compositions for treatment of pain using capsaicinCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Jan 21, 2025·0 cites·29 claims
- 3773US11517546B2High concentration local anesthetic formulationsCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Dec 6, 2022·0 cites·23 claims
- 3870US11872219B2Compositions and methods for intrathecal administration of MCOPPB for pain reliefCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Jan 16, 2024·0 cites·34 claims
- 3969US2020375926A1Injectable resiniferatoxinCENTREXION THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4069US2020206166A1Methods and compositions for treatment of pain using capsaicinCENTREXION THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 4165US2025205214A1Compositions and methods for epidural administration of mcoppb for pain reliefCENTREXION THERAPEUTICS CORP·Filed 2025·Application pending·0 cites
- 4264US2024383892A1PARTICLES OF IMIDAZO[4,5-b]PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL CONDITIONSCENTREXION THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 4363US2020338064A1High concentration local anesthetic formulationsCENTREXION THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4461US2017266139A1Injectable resiniferatoxinCENTREXION THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 4558US2021145772A1Capsaicinoids for use in treating acral lick granulomaCENTREXION THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4657US2017014359A1High concentration local anesthetic formulationsCENTREXION THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 4755US2020297670A1Capsaicin Sequential Dosing Method for Treatment of Morton's Neuroma PainCENTREXION THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4854US2021322412A1Methods and compositions for treating a coronavirus infectionCENTREXION THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 4954US2019022036A1Capsaicin sequential dosing method for treatment of morton's neuroma painCENTREXION THERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 5052US2018311189A1Capsaicinoids for Use in Treating ACRAL Lick GranulomaCENTREXION THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CENTREXION THERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →